Literature DB >> 9818055

Fibrinogen A alpha chain Leu 554: an African-American kindred with late onset renal amyloidosis.

T Uemichi1, J J Liepnieks, M A Gertz, M D Benson.   

Abstract

An African-American kindred with renal amyloidosis is described. Four members in two generations developed nephropathy in the sixth to eighth decade of life. Kidney biopsy and subcutaneous fat aspirate biopsy of one patient revealed amyloid deposits. DNA analysis showed that patients were heterozygous for a mutation in the fibrinogen A alpha chain gene with a guanine to thymine transversion at the second base of codon 554, predicting a leucine for arginine substitution. Peptide sequence analysis of isolated plasma fibrinogen showed normal peptide as well as variant peptide with leucine replacing arginine at position 554, as predicted by the DNA sequence. The ratio between normal and variant peptides was approximately 1:1 in one patient and 3:2 in another. Although this African-American kindred has the exact same mutation as a previously described Peruvian-Mexican kindred, the onset age in this kindred is much later than in the Peruvian-Mexican kindred. This finding may indicate the existence of additional factor(s) beside the primary causative genetic mutation, which affect the expression of the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818055     DOI: 10.3109/13506129809003844

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  3 in total

1.  Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation.

Authors:  Magdalena Eriksson; Stefan Schönland; Raoul Bergner; Ute Hegenbart; Peter Lohse; Hartmut Schmidt; Christoph Röcken
Journal:  Virchows Arch       Date:  2008-05-24       Impact factor: 4.064

Review 2.  Amyloid in surgical pathology.

Authors:  Christoph Röcken; Knut Sletten
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

3.  MetAmyl: a METa-predictor for AMYLoid proteins.

Authors:  Mathieu Emily; Anthony Talvas; Christian Delamarche
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.